GSA CAPITAL PARTNERS LLP

Position in OMER — Omeros Corp

CIK 1362033 LONDON, X0

Position in OMER

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$253,091

+$212,075 QoQ

Shares Held

23,967

+139.6% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $101,563,069 across 163 Biotechnology names. OMER ranks #109 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,831	$2,959,983
2	ARDX	Ardelyx, Inc.	473,061	$2,833,635
3	NTLA	Intellia Therapeutics, Inc.	178,301	$2,285,818
4	NUVB	Nuvation Bio Inc.	495,792	$2,126,947
5	RXRX	Recursion Pharmaceuticals, Inc.	669,568	$2,055,573
6	WVE	Wave Life Sciences Ltd.	282,719	$2,049,712
7	SRPT	Sarepta Therapeutics, Inc.	90,960	$1,979,289
8	IOVA	Iovance Biotherapeutics, Inc.	557,085	$1,955,368

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$253,091	23,967	+139.6%	Shares	Sole	2026-05-08
2025-09-30	$41,016	10,004	-73.8%	Shares	Sole	2025-11-07
2025-06-30	$114,396	38,132	+77.5%	Shares	Sole	2025-07-22
2024-06-30	$87,216	21,482	-1.3%	Shares	Sole	2024-08-15
2024-03-31	$75,054	21,755	-56.6%	Shares	Sole	2024-05-03
2023-03-31	$232,834	50,072	+10.5%	Shares	Sole	2023-05-12
2021-12-31	$291,330	45,308	-29.0%	Shares	Sole	2022-02-14
2021-09-30	$879,388	63,770	-46.8%	Shares	Sole	2021-11-12
2021-06-30	$1,779,909	119,940	+690.8%	Shares	Sole	2021-08-05
2020-09-30	$153,328	15,166	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.